Literature DB >> 25901083

Preanalytical considerations in the design of clinical trials and epidemiological studies.

Mark D Kellogg1, Christina Ellervik2, David Morrow3, Ann Hsing4, Evan Stein5, Amar A Sethi6.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25901083     DOI： 10.1373/clinchem.2014.226118

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  Standardizing in vitro diagnostics tasks in clinical trials: a call for action.

Authors:  Giuseppe Lippi; Ana-Maria Simundic; Leocadio Rodriguez-Manas; Patrick Bossuyt; Giuseppe Banfi
Journal:  Ann Transl Med       Date:  2016-05

2.  Analytes related to erythrocyte metabolism are reliable biomarkers for preanalytical error due to delayed plasma processing in metabolomics studies.

Authors:  Mahim Jain; Adam D Kennedy; Sarah H Elsea; Marcus J Miller
Journal:  Clin Chim Acta       Date:  2017-01-06       Impact factor: 3.786

Review 3.  The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples.

Authors:  Mads V Lind; Otto I Savolainen; Alastair B Ross
Journal:  Eur J Epidemiol       Date:  2016-05-26       Impact factor: 8.082

4.  The impact of preanalytical variability in clinical trials: are we underestimating the issue?

Authors:  Giuseppe Banfi; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.